Drug intelligence / Profile preview

allogeneic adipose tissue-derived mesenchymal stromal cells

Development stage
Phase 2
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intrathecal, Subcutaneous, Local (e.g., Perilesional For Wound Healing)
01

Overview

Allogeneic adipose tissue-derived mesenchymal stromal cells are a type of multipotent adult stem cell isolated from human adipose (fat) tissue and expanded ex vivo for therapeutic use. As an allogeneic product, the cells are obtained from a donor and administered to a different individual. AD-MSCs display immunomodulatory, anti-inflammatory, pro-regenerative, and pro-angiogenic properties, primarily through release of paracrine factors. In clinical and preclinical studies, these cells have been shown to regulate inflammatory responses, modulate immune cell function, stimulate tissue regeneration, and promote wound healing. Mechanistically, their effects are linked to modulation of immune pathways, stimulation of endogenous tissue repair, and secretion of trophic factors that support cell survival and angiogenesis. AD-MSCs are being investigated in regenerative medicine for a wide array of conditions, including traumatic and degenerative diseases (e.g., spinal cord injury, Crohn's disease with perianal fistula, diabetes, wound healing disorders, and neurodegenerative conditions)[1][2][3][4].

Other names
adipose-derived mesenchymal stromal cellsadipose-derived mesenchymal stem cellsAD-MSCs

Beyond the preview

Go deeper on allogeneic adipose tissue-derived mesenchymal stromal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic adipose tissue-derived mesenchymal stromal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call